Article | August 22, 2017

Using eCOA For The First Time

Source: ERT

By Dascha Turner, LIC.PHIL.I, Clinical Psychologist

Using eCOA For The First Time

The importance of patient-reported outcomes (PRO) is evidenced by their increased use in clinical trials and in drug and device label claims. In many cases, the best way to measure symptoms and functional status is through insights provided by the patient, but few people know how to go about integrating ePRO into their clinical trials. Download this white paper to learn about a completed a Phase 2 clinical trial that used electronic PRO for the first time and identified the key decision points, responsibilities and lessons learned for incorporating ePRO into clinical trial practices.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: